In accordance with our study, the autocrine actions of hGH in promoting oncogenic behaviour in several cancers, including mammary, endometrial and hepatocellular carcinomas, have been reported [21, 23, 27, 31, 57]. This evidence concerns the gene GH1 and hepatocellular carcinoma.